Skip directly to search
Skip directly to A to Z list
Skip directly to navigation
Skip directly to page options
Skip directly to site content
Start of Search Controls
Search Form Controls
Search The CDC
submit
CDC A-Z Index
MENU
CDC A-Z
SEARCH
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Search Form Controls
Search The CDC
submit
CDC A-Z Index
Public Health Genomics and Precision Health Knowledge Base (v9.0)
PHGKB
About
Public Health Genomics Branch
PHGKB Weekly Horizon Scan
Genomics Precision Health Scan
Advanced Molecular Detection Clips
Non-Genomics Precision Health Scan
CDC-authored Publications Scan
Specialized PHGKB
Cancer PHGKB
Diabetes PHGKB
Economic Evaluation PHGKB
Environmental Health PHGKB
Family Health History PHGKB
Health Equity PHGKB
HLBS-PopOmics
Infectious Diseases PHGKB
Implementation Science PHGKB
Neurological Disorders PHGKB
Pharmacogenomics PHGKB
Primary Immune Deficiency Diseases PHGKB
Rare Diseases PHGKB
Reproductive and Child Health PHGKB
All Databases
COVID-19 GPH (47370)
CDC/NIH Web Information Database (32181)
CDC-Authored Genomics and Precision Health Publications Database (5878)
Precision Health Database (63675)
Tier-Classified Guidelines Database (534)
Pathogen Advanced Molecular Detection Database (26775)
All of Us Reports and Publications Database (676)
Human Genome Epidemiology
Human Genome Epidemiology Literature Finder (226516)
Epigenetic Epidemiology Publications Database (22780)
Release Note
Contact Us
Precision Health Database
Precision Health Database|Search|Public Health Genomics and Precision Health Knowledge Base (PHGKB)
Rare Diseases
Last data update: Apr 25, 2024
. (Total: 63675 Documents since 2012)
All
Cancer
Diabetes
Economic
Environmental
Equity
FHH
HLBS
ID
Implementation
ND
PGx
PI
Rare
RCH
dataset
All
GPH
Non-GPH
Filtered By
:
Select to fine-tune your search
Disease
Gene
Product Type
Category
Year
Previous
Records 1 - 29 (of 29 Records)
Query Trace:
A Phenogenetic Axis that Modulates Clinical Manifestation and Predicts Treatment Outcome in Primary Myeloid Neoplasms.
Qiujin Shen et al. Cancer research communications 2023 2(4) 258-276
Similar articles in PubMed
Impact of gene alterations on clinical outcome in young adults with myelodysplastic syndromes.
Tatsuya Konishi et al. Scientific reports 2023 13(1) 2641
Similar articles in PubMed
MDS-287 Genetic Landscape of Somatic Myeloid Mutations in the Presence of Rare TERT Variants and Their Relation to Myeloid Neoplasia.
Ferrer Alejandro et al. Clinical lymphoma, myeloma & leukemia 2022 22 Suppl 2S309
Similar articles in PubMed
TP53 Combined Phenotype Score Is Associated with the Clinical Outcome of TP53-Mutated Myelodysplastic Syndromes.
Yabe Mariko et al. Cancers 2021 13(21)
Similar articles in PubMed
A Geno-Clinical Decision Model for the Diagnosis of Myelodysplastic Syndromes.
Radakovich Nathan et al. Blood advances 2021
Similar articles in PubMed
Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers.
Duncavage Eric J et al. The New England journal of medicine 2021 384(10) 924-935
Similar articles in PubMed
GATA2 Related Conditions and Predisposition to Pediatric Myelodysplastic Syndromes.
Bruzzese Antonella et al. Cancers 2020 Oct 12(10)
Similar articles in PubMed
Cyclosporine Broadens the Therapeutic Potential of Lenalidomide in Myeloid Malignancies.
Dou Aixia et al. Journal of cellular immunology 2020 2(5) 237-244
Similar articles in PubMed
Behçet disease (BD) and BD-like clinical phenotypes: NF-kB pathway in mucosal ulcerating diseases.
Perazzio Sandro F et al. Scandinavian journal of immunology 2020 Sep e12973
Similar articles in PubMed
Genetic Predisposition to Myelodysplastic Syndrome in Clinical Practice.
Schratz Kristen E et al. Hematology/oncology clinics of North America 2020 Apr 34(2) 333-356
Similar articles in PubMed
Wide variation in use and interpretation of gene mutation profiling panels among health care providers of patients with myelodysplastic syndromes: results of a large web-based survey.
Pine Alexander B et al. Leukemia & lymphoma 2020 Feb 1-10
Similar articles in PubMed
Genetic predisposition to MDS: diagnosis and management.
Furutani Elissa et al. Hematology. American Society of Hematology. Education Program 2019 Dec 2019(1) 110-119
Similar articles in PubMed
Genomic Biomarkers to Predict Resistance to Hypomethylating Agents in Patients With Myelodysplastic Syndromes Using Artificial Intelligence.
Nazha Aziz et al. JCO precision oncology 2019 3
Similar articles in PubMed
Clinical Outcomes With Ring Sideroblasts and SF3B1 Mutations in Myelodysplastic Syndromes: MDS Clinical Research Consortium Analysis.
Migdady Yazan et al. Clinical lymphoma, myeloma & leukemia 2018 18(8) 528-532
Similar articles in PubMed
Targeted Next-Generation Sequencing Is a Sensitive Tool for Differential Diagnosis of Myelodysplastic Syndromes in Bone Marrow Trephines.
Bräuninger Andreas et al. The Journal of molecular diagnostics : JMD 2018 20(3) 344-354
Similar articles in PubMed
Local Coverage Determination (LCD): Flow Cytometry (L33661)
The U.S. Centers for Medicare & Medicaid Services
Local Coverage Determination (LCD): Genomic Sequence Analysis Panels in the Treatment of Hematolymphoid Diseases (L37606)
The U.S. Centers for Medicare & Medicaid Services
Clinical applicability of proposed algorithm for identifying individuals at risk for hereditary hematologic malignancies.
Clifford Maggie et al. Leukemia & lymphoma 2019 Jul 1-8
Similar articles in PubMed
A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patients.
Drusbosky Leylah M et al. Blood advances 2019 Jun 3(12) 1837-1847
Similar articles in PubMed
Genetics of MDS.
Ogawa Seishi et al. Blood 2019 Jan
Similar articles in PubMed
The MDS genomics-prognosis symbiosis.
Nazha Aziz et al. Hematology. American Society of Hematology. Education Program 2018 Nov 2018(1) 270-276
Similar articles in PubMed
Current and Future Treatment Options for Myelodysplastic Syndromes: More Than Hypomethylating Agents and Lenalidomide?
Sockel Katja et al. Drugs 2018 Nov
Similar articles in PubMed
Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use.
Bacher Ulrike et al. Blood cancer journal 2018 Nov 8(11) 113
Similar articles in PubMed
How I use molecular genetic tests to evaluate patients who have or may have myelodysplastic syndromes.
Steensma David P et al. Blood 2018 Sep
Similar articles in PubMed
Clinical Significance of DNA Variants in Chronic Myeloid Neoplasms (CMNs): A Report of the Association for Molecular Pathology.
McClure Rebecca F et al. The Journal of molecular diagnostics : JMD 2018 Aug
Similar articles in PubMed
Implications of Mutation Profiling in Myeloid Malignancies-PART 1: Myelodysplastic Syndromes and Acute Myeloid Leukemia.
Tremblay Douglas et al. Oncology (Williston Park, N.Y.) 2018 32(4) e38-e44
Similar articles in PubMed
Challenges in Diagnosing Myelodysplastic Syndromes in the Era of Genetic Testing: Proceedings of the 13th Workshop of the European Bone Marrow Working Group.
Hebeda Konnie M et al. Pathobiology : journal of immunopathology, molecular and cellular biology 2018 Jul 1-14
Similar articles in PubMed
Routine clinical mutation profiling using next generation sequencing and a customized gene panel improves diagnostic precision in myeloid neoplasms.
Bartels Stephan et al. Oncotarget 2016 May 7(21) 30084-93
Similar articles in PubMed
The evolving role of genomic testing in assessing prognosis of patients with myelodysplastic syndromes.
Steensma David P et al. Best practice & research. Clinical haematology 2017 Dec 30(4) 295-300
Similar articles in PubMed
File Formats Help:
How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?
Adobe PDF file
Microsoft PowerPoint file
Microsoft Word file
Microsoft Excel file
Audio/Video file
Apple Quicktime file
RealPlayer file
Text file
Zip Archive file
SAS file
ePub file
Page last reviewed:
Feb 1, 2024
Page last updated:
Apr 25, 2024
Content source:
Public Health Genomics Branch in the Division of Blood Disorders and Public Health Genomics
,
National Center on Birth Defects and Developmental Disabilities
TOP